Page last updated: 2024-08-24

thymidine 5'-triphosphate and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

thymidine 5'-triphosphate has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aktoudianakis, V; Appleby, TC; Babusis, D; Barauskas, O; Birkus, G; Butler, T; Byun, D; Chin, G; Cho, A; Clarke, MO; Doerffler, E; Edwards, TE; Fenaux, M; Feng, JY; Kim, CU; Kirschberg, TA; Lee, R; Lew, W; Metobo, S; Mish, MR; Murakami, E; Park, Y; Ray, AS; Squires, NH; Tirunagari, N; Wang, T; Whitcomb, M; Xu, J; Yang, H; Ye, H; Zhang, L	1

Other Studies

1 other study(ies) available for thymidine 5'-triphosphate and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

Article	Year
Discovery of a 2'-fluoro-2'-C-methyl C-nucleotide HCV polymerase inhibitor and a phosphoramidate prodrug with favorable properties. Bioorganic & medicinal chemistry letters, 2017, 04-15, Volume: 27, Issue:8 Topics: Amides; Animals; Antiviral Agents; Caco-2 Cells; Cell Line; Cricetinae; Drug Discovery; Drug Resistance, Viral; Halogenation; Hepacivirus; Hepatitis C; Humans; Methylation; Molecular Docking Simulation; Nucleosides; Phosphoric Acids; Point Mutation; Prodrugs; Viral Nonstructural Proteins; Virus Replication	2017

Article

Year

Discovery of a 2'-fluoro-2'-C-methyl C-nucleotide HCV polymerase inhibitor and a phosphoramidate prodrug with favorable properties.

Bioorganic & medicinal chemistry letters, 2017, 04-15, Volume: 27, Issue:8

Topics: Amides; Animals; Antiviral Agents; Caco-2 Cells; Cell Line; Cricetinae; Drug Discovery; Drug Resistance, Viral; Halogenation; Hepacivirus; Hepatitis C; Humans; Methylation; Molecular Docking Simulation; Nucleosides; Phosphoric Acids; Point Mutation; Prodrugs; Viral Nonstructural Proteins; Virus Replication

2017